All cancer types
Results
Phase 1
This study looked at a drug called capivasertib (AZD5363) for people who had a solid tumour that had got worse despite treatment.
A is any type of cancer apart from cancer of the blood or lymphatic system such as:
This study was open for people to join in the UK between 2010 and 2018. The researchers published the results from the first parts of the study in 2017. They presented some other results at a conference in 2019.
Recruitment start: 1 December 2010
Recruitment end: 30 June 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Udai Banerji
AstraZeneca
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 17 August 2021
CRUK internal database number: 7514
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
